ALSUntangled Update 1: Investigating a bug (Lyme Disease) and a drug (Iplex) on behalf of people with ALS

被引：10

作者：

Bedlack, Richard

Hardiman, Orla

Bowser, Robert

Drory, Vivian

Shefner, Jeremy

Heiman-Patterson, Terry

Lechtzin, Noah

Leitner, Melanie

Miller, Robert

Mitsumoto, Hiroshi

Levine, Todd

Russell, James

Sharma, Khema

Saperstein, David

McClusky, Leo

MacGowan, Daniel

Licht, Jonathan

Verma, Ashok

Strong, Michael

Lomen-Hoerth, Catherine

Tandan, Rup

Rivner, Michael

Krivickas, Lisa

Kolb, Steve

Polak, Meraida

Rudnicki, Stacy

Kittrell, Pamela

Quereshi, Muddasir

Sachs, George

Pattee, Gary

Mozaffar, Tahseen

Weiss, Michael

Kissel, John

Cudkowicz, Merit

Goldstein, Jonathan

Rothstein, Jeffrey

Traynor, Bryan

Pastula, Dan

机构：

来源：

AMYOTROPHIC LATERAL SCLEROSIS | 2009年 / 10卷 / 04期

关键词：

AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; GROWTH-FACTOR-I; BORRELIA-BURGDORFERI; TRIAL;

D O I：

10.1080/17482960903208599

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：248 / 250

页数：3

共 12 条

[1]

BEDLACK RS, 2009, ALS, V10

[2] A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis [J].

Borasio, GD ;

Robberecht, W ;

Leigh, PN ;

Emile, J ;

Guiloff, RJ ;

Jerusalem, F ;

Silani, V ;

Vos, PE ;

Wokke, JHJ ;

Dobbins, T .

NEUROLOGY, 1998, 51 (02) :583-586

[3]

CDC, 1995, REC TEST PERF INT 2

[4] Practice parameter: Treatment of nervous system Lyme disease (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology [J].

Halperin, J. J. ;

Shapiro, E. D. ;

Logigian, E. ;

Belman, A. L. ;

Dotevall, L. ;

Wormser, G. P. ;

Krupp, L. ;

Gronseth, G. ;

Bever, C. T., Jr. .

NEUROLOGY, 2007, 69 (01) :91-102

[5] IMMUNOLOGICAL REACTIVITY AGAINST BORRELIA-BURGDORFERI IN PATIENTS WITH MOTOR-NEURON DISEASE [J].

HALPERIN, JJ ;

KAPLAN, GP ;

BRAZINSKY, S ;

TSAI, TF ;

CHENG, T ;

IRONSIDE, A ;

WU, P ;

DELFINER, J ;

GOLIGHTLY, M ;

BROWN, RH ;

DATTWYLER, RJ ;

LUFT, BJ .

ARCHIVES OF NEUROLOGY, 1990, 47 (05) :586-594

[6] Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease) [J].

Halperin, JJ ;

Logigian, EL ;

Finkel, MF ;

Pearl, RA .

NEUROLOGY, 1996, 46 (03) :619-627

[7] Motor neuron disease recovery associated with IV ceftriaxone and anti-Babesia therapy [J].

Harvey, W. T. ;

Martz, D. .

ACTA NEUROLOGICA SCANDINAVICA, 2007, 115 (02) :129-131

[8] Effect of recombinant human insulin-like growth factor-I on progression of ALS - A placebo-controlled study [J].

Lai, EC ;

Felice, KJ ;

Festoff, BW ;

Gawel, MJ ;

Gelinas, DF ;

Kratz, R ;

Murphy, MF ;

Natter, HM ;

Norris, FH ;

Rudnicki, SA .

NEUROLOGY, 1997, 49 (06) :1621-1630

[9]

MURPHREE B, 2008, SURVEILLANCE LYME DI

[10] Subcutaneous IGF-1 is not beneficial in 2-year ALS trial [J].

Sorenson, E. J. ;

Windbank, A. J. ;

Mandrekar, J. N. ;

Bamlet, W. R. ;

Appel, S. H. ;

Armon, C. ;

Barkhaus, P. E. ;

Bosch, P. ;

Boylan, K. ;

David, W. S. ;

Feldman, E. ;

Glass, J. ;

Gutmann, L. ;

Katz, J. ;

King, W. ;

Luciano, C. A. ;

McCluskey, L. F. ;

Nash, S. ;

Newman, D. S. ;

Pascuzzi, R. M. ;

Pioro, E. ;

Sams, L. J. ;

Scelsa, S. ;

Simpson, E. P. ;

Subramony, S. H. ;

Tiryaki, E. ;

Thornton, C. A. .

NEUROLOGY, 2008, 71 (22) :1770-1775

← 1 2 →